Evidence map›Paper›PMID 25822012›Full record

ArticleInflammatory bowel diseases2015

Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?

Felix Becker, Sergey Potepalov, Romana Shehzahdi, Michael Bernas, Marlys Witte, Fleurette Abreo, James Traylor, Wayne A Orr, Ikuo Tsunoda, Jonathan Steven Alexander

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Neutrophils in tumor- and inflammation-induced lymphangiogenesis.International journal of biological sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Glucose transporter expression in the human colon.World journal of gastroenterology · 2018
    Article
  17. Intestinal lymphatic vasculature: structure, mechanisms and functions.Nature reviews. Gastroenterology & hepatology · 2017
    Review
  18. Downregulation of CXInternational journal of colorectal disease · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Felix Becker*Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana; †Department for General and Visceral Surgery, University of Münster, Münster, Germany; ‡Department of Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana; §Department of Surgery, University of Arizona, Tucson, Arizona; Departments of ‖Pathology, ¶Cellular Biology and Anatomy, and **Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana.
Sergey Potepalov
Romana Shehzahdi
Michael Bernas
Marlys Witte
Fleurette Abreo
James Traylor
Wayne A Orr
Ikuo Tsunoda
Jonathan Steven Alexander
Louisiana State University Health Sciences Center Shreveport · USUniversity of Arizona · USUniversity of Münster · DE

Funding

COBRE Center for Molecular and Tumor VirologyP30GM110703 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI SAPP, MARTIN · 2014 to 2018
$4.8M
NIGMS NIH HHS P30 GM110703NIGMS NIH HHS P30-GM110703
6 · The paper itself

Abstract

backgroundAlthough inflammation-induced expansion of the intestinal lymphatic vasculature (lymphangiogenesis) is known to be a crucial event in limiting inflammatory processes, through clearance of interstitial fluid and immune cells, considerably less is known about the impact of an impaired lymphatic clearance function (as seen in inflammatory bowel diseases) on this cascade. We aimed to investigate whether the impaired intestinal lymphatic drainage function observed in FoxC2 mice would influence the course of disease in a model of experimental colitis.

methodsAcute dextran sodium sulfate colitis was induced in wild-type and haploinsufficient FoxC2 mice, and survival, disease activity, colonic histopathological injury, neutrophil, T-cell, and macrophage infiltration were evaluated. Functional and structural changes in the intestinal lymphatic vessel network were analyzed, including submucosal edema, vessel morphology, and lymphatic vessel density.

resultsWe found that FoxC2 downregulation in FoxC2 mice significantly increased the severity and susceptibility to experimental colitis, as displayed by lower survival rates, increased disease activity, greater histopathological injury, and elevated colonic neutrophil, T-cell, and macrophage infiltration. These findings were accompanied by structural (dilated torturous lymphatic vessels) and functional (greater submucosal edema, higher immune cell burden) changes in the intestinal lymphatic vasculature.

conclusionsThese results indicate that sufficient lymphatic clearance plays a crucial role in limiting the initiation and perpetuation of experimental colitis and those disturbances in the integrity of the intestinal lymphatic vessel network could intensify intestinal inflammation. Future therapies might be able to exploit these processes to restore and maintain adequate lymphatic clearance function in inflammatory bowel disease.

Indexed as

AnimalsColitisColonDextran SulfateDisease Models, AnimalDown-RegulationFemaleForkhead Transcription FactorsIntestinal MucosaLymphangiogenesisLymphatic VesselsMaleMiceNeutrophil InfiltrationSurvival RateDextran SulfateForkhead Transcription Factorsmesenchyme fork head 1 protein

Identifiers

PMID25822012
PMCPMC4437831
OpenAlexW2086428984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.